glp-1 agonists vision loss blindness A nurse lost her eyesight while on drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S GLP 1 Blindness Risk |
Description
Investigating GIPR (ant)agonism: a structural analysis of GIP and its receptor

Glucagon-like peptide-1 receptor agonists in the treatment of idiopathic inflammatory myopathy: from mechanisms of action to clinical applications
N.BaxterS
[DOI] [PMC free article] [PubMed] [Google Scholar] 203.Algotar A., Trofymenko S., Muramoto M., Howerter A., Kutob R

Bray, R

Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases
